Full-Time

Brand and Communication Specialist

Zeiss

Zeiss

1,001-5,000 employees

Corporate venture capital for deep-tech startups

No salary listed

Bengaluru, Karnataka, India

In Person

Master's

Category
Growth & Marketing (1)
Required Skills
Microsoft Office
SEO
Google Analytics

Get referred to Zeiss

See people who can refer or advise you

Requirements
  • The candidate must have 3–5 years of experience in marketing communications or digital marketing, preferably in the healthcare, pharmaceutical, medical technology, or healthcare creative agency domain.
  • The candidate must have experience in social media marketing, including organic and paid campaigns, web and digital content marketing, search engine optimization, search engine marketing, and other digital platforms.
  • The candidate must have a Master's Degree in Marketing, Communications, or a related field.
  • The candidate must have robust knowledge of integrated marketing communications and digital marketing strategies.
  • The candidate must have excellent oral and written communication skills.
  • The candidate must be able to motivate and work effectively with diverse, cross-functional global teams and external vendors.
  • The candidate must be able to operate under pressure, within tight deadlines, and in dynamic environments.
  • The candidate must have knowledge of Microsoft Office, marketing automation, technical and digital tools, including Marketo, Adobe, Sitecore, Google Analytics, Adobe Analytics, SEMrush, and content management platforms.
  • The candidate must have demonstrated project management and budget management skills.
  • The candidate must have strong business acumen, analytical and process skills, and the ability to translate outputs into outcomes while remaining detail-oriented.
Responsibilities
  • Develop clear and compelling brand messaging and visual content for marketing materials, presentations, digital platforms, and product collateral.
  • Collaborate with the Strategic Marketing and Product Management teams to create consistent and effective messaging that supports product positioning and customer engagement.
  • Plan and execute integrated marketing campaigns across digital, print, and social media channels to raise awareness and promote the OPT product portfolio.
  • Track and analyze campaign performance to optimize content and strategies for improved engagement and reach.
  • Organize and manage logistics for participation in industry conferences, tradeshows, and continuing medical education events, including booth design, event materials, and branding.
  • Work with the Strategic Marketing Manager to align event themes and objectives with broader marketing and sales goals, ensuring cohesive brand representation.
  • Develop event-specific product campaigns to increase booth footfall.
  • Serve as the point person for external communications, including press releases, newsletters, product announcements, and media relations, ensuring alignment with brand standards.
  • Manage internal communications to keep sales, product teams, and other stakeholders informed about upcoming events, marketing activities, and product updates.
  • Adapt global branding and marketing communications programs and campaigns for the region in alignment with business and marketing strategy.
  • Ensure adherence to corporate branding and integrate corporate guidelines into communication programs.
  • Oversee digital marketing initiatives, including website content updates, social media management, and email campaigns, to increase product visibility and engagement.
  • Maintain and monitor social media channels, post relevant content, and engage with followers to build brand awareness and strengthen customer relationships.
  • Develop, manage, and update marketing materials, including brochures, flyers, banners, and other collateral for events, sales support, and product promotions.
  • Ensure marketing materials are current, accessible, and consistent with brand guidelines, and provide the sales team with high-quality resources for customer interactions.
  • Manage relationships with external vendors, agencies, and printers to ensure quality and timely production of marketing assets.
  • Oversee the marketing communications and event budget, ensuring cost-effective resource allocation and maximizing return on investment.
  • Collaborate with the Strategic Marketing and Sales teams to develop customer engagement initiatives, including webinars, virtual workshops, and educational series, to support customer retention and loyalty.
  • Plan and promote content for customer engagement programs to drive attendance, engagement, and brand loyalty.
  • Track and analyze the effectiveness of trade shows and events, including attendance, lead generation, and customer engagement metrics.
  • Provide detailed post-event reports to assess return on investment, identify areas for improvement, and recommend enhancements for future events.

ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, investing in deep-tech startups in Information Technology, Industrial Tech, MedTech, and Life Sciences. It backs early-stage companies at pre-Series A to Series A with typical investments of $1–5 million. The fund provides capital and tailored funding solutions, leveraging ZEISS’s global network and optics/optoelectronics expertise to support portfolio companies. Its goal is to accelerate the development of new technologies and business models that complement ZEISS’s portfolio while actively engaging with external innovation.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$67.7M

Headquarters

Oberkochen, Germany

Founded

2001

Get referred to Zeiss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ZEISS led Maculaser's May 2026 round for retinal laser therapy commercialization.
  • ZEISS Ventures led SeeTrue's €2.2 million round on August 6, 2026.
  • ZEISS launched ClearMind lenses and DuraVision Plus in January 2026, reinforcing optical leadership.

What critics are saying

  • Carl Zeiss Meditec cut 2026 revenue 5.7% and targets 1,000 job reductions.
  • ZEISS's 2026 restructuring threatens innovation velocity and employee morale through 2028/29.
  • A prolonged MedTech slump or failed turnaround would weaken ZEISS Ventures' strategic value.

What makes Zeiss unique

  • ZEISS Ventures pairs capital with ZEISS distribution, engineering, and ophthalmology channels.
  • Its 2026 deals target eye health, imaging, and optoelectronics adjacencies.
  • ZEISS brand credibility de-risks pilots for startups selling into regulated healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

PR Newswire
Aug 19th, 2026
ZEISS CLINIC 360 receives FDA clearance for cloud-based ophthalmic data management software

ZEISS Medical Technology announced FDA 510(k) clearance for ZEISS CLINIC 360, a cloud-based software solution that aggregates ophthalmic clinical data and provides advanced analytics. The browser-based platform combines diagnostic and medical data into a comprehensive patient view, helping clinicians evaluate disease progression and support treatment decisions. The solution integrates data from DICOM-enabled diagnostic devices, including ZEISS's CIRRUS, CLARUS and HFA systems, as well as third-party devices. It features disease-based summaries, interactive analysis tools, and collaboration capabilities through ZEISS Collaborative Care. ZEISS CLINIC 360 will be available in the US in early autumn 2026 on a subscription basis with low upfront costs. The platform complements ZEISS FORUM, the company's on-premise data management system, giving providers flexibility in choosing their preferred infrastructure approach.

ZEISS
Aug 5th, 2026
ZEISS leads $2.5M investment in SeeTrue Technologies for miniaturised eye-tracking tech

ZEISS Ventures led a €2.2 million investment round in SeeTrue Technologies, a Finnish deep-tech company developing miniaturised eye-tracking technology. The funding will accelerate commercialisation of SeeTrue's ultra-low-power eye-sensing architecture for next-generation interfaces in smart optical systems and eyewear. SeeTrue's proprietary technology combines miniaturised sensing hardware with optimised embedded processing, enabling scalable eye-sensing capabilities with low power consumption and small hardware footprint. The technology supports gaze-based interaction and attention-aware computing across healthcare, industrial, and smart eyewear applications. The investment round includes participation from Superhero Capital and North Karelia Growth Fund, managed by Redstone Nordics. Founded in 2018 and based in Joensuu, Finland, SeeTrue develops ultra-miniature eye-tracking technology for medical optical systems, vision care, and smart wearables.

PR Newswire
Jun 11th, 2026
ZEISS completes early implantations of AT LUCIA toric 721P intraocular lens

ZEISS Medical Technology has announced successful early clinical implantations of its AT LUCIA toric 721P intraocular lens, designed to treat cataracts whilst correcting astigmatism. The company is conducting an early-access clinical trial with experienced surgeons across six European countries. The lens combines an aspheric bitoric optic with a patented non-constant aberration design on a fully preloaded, hydrophobic platform. Surgeons have reported positive early impressions, highlighting the lens's precision, stability and surgical handling. Currently CE marked, the AT LUCIA toric 721P will be showcased at the International Congress of German Ophthalmic Surgery in Nuremberg from 18–20 June 2026. The lens is expected to be commercially available in select European countries later this year.

ZEISS
May 28th, 2026
ZEISS invests in Maculaser to advance temperature-controlled retinal laser therapy

ZEISS Ventures has invested in Maculaser, a Finnish medtech company developing temperature-controlled retinal laser therapy, through a funding round co-led with M2care. The investment will support clinical development of the company's personalized treatment for retinal diseases. Founded in 2020 and based on research from Aalto University, Maculaser has developed patented technology that provides real-time temperature control during laser treatment. The non-damaging approach activates natural cellular defence mechanisms, targeting affected retinal areas early to delay or prevent progression of age-related macular degeneration and diabetic maculopathy. The technology aims to shift retinal care from managing late-stage damage to proactive vision preservation, offering an outpatient procedure that integrates into regular eye care. Maculaser plans to bring the treatment into clinical practice to benefit millions of patients worldwide.

PR Newswire
May 13th, 2026
ZEISS gains COFEPRIS approval for ARTEVO 850 and MICOR 700 ophthalmic surgical systems in Mexico

ZEISS Medical Technology has received approval from Mexico's COFEPRIS for two ophthalmic surgical devices: the ARTEVO 850 microscope and MICOR 700 lens removal device. Both technologies are compatible with ZEISS's latest cataract workflow systems. The ARTEVO 850 is a 3D heads-up ophthalmic microscope offering true colour imaging and a nearly 60% increase in depth of field. The MICOR 700 is the first handheld lens removal device with ultrasound-free operation, using ZEISS's non-ultrasonic lens extraction procedure to minimise risk to surrounding eye structures. The products will be showcased at the Mexican Congress of Ophthalmology in Monterrey from 30 May to 3 June 2026. ZEISS Medical Technology generated revenue of €2,066.1 million in fiscal year 2023/24.